Ask the Expert: Front-Line Therapy Updates and How LAG3 Will Impact Treatment
Want to learn the latest updates in cutaneous melanoma treatments? Ask the Expert!
On Friday, June 24 at 1pm ET, Dr. Jason Luke, Director of the Immunotherapy and Drug Development Center at UPMC Hillman Cancer Center, will join the MRF for a live discussion and Q&A on Zoom. Learn about the current state of front-line therapies and how research into the LAG3 gene could impact current and future treatments.
Register today, and then bring your questions for Dr. Luke on Friday, June 24!